The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125569802 12556980 2 F 20150216 20160822 20160714 20160825 EXP ES-AMGEN-ESPSP2016091295 AMGEN 60.00 YR A F Y 0.00000 20160825 MD ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125569802 12556980 1 PS NEUPOGEN FILGRASTIM 1 Unknown UNK 103353 UNKNOWN FORMULATION
125569802 12556980 2 SS CYTARABINE. CYTARABINE 1 Unknown UNK 0
125569802 12556980 3 SS VINCRISTINE VINCRISTINE 1 Unknown UNK 0
125569802 12556980 4 SS FLUDARABINE PHOSPHATE. FLUDARABINE PHOSPHATE 1 Unknown UNK 0
125569802 12556980 5 SS FLUDARABINE PHOSPHATE. FLUDARABINE PHOSPHATE 1 Unknown UNK 0
125569802 12556980 6 SS PREDNISONE. PREDNISONE 1 Unknown UNK 0
125569802 12556980 7 SS PREDNISONE. PREDNISONE 1 Unknown UNK 0
125569802 12556980 8 SS MELPHALAN MELPHALAN 1 Unknown UNK 0
125569802 12556980 9 SS TACROLIMUS. TACROLIMUS 1 Unknown UNK 0
125569802 12556980 10 SS RAPAMYCIN SIROLIMUS 1 Unknown UNK 0
125569802 12556980 11 C ASPARAGINASE ASPARAGINASE 1 UNK 0
125569802 12556980 12 C IDARUBICIN IDARUBICIN 1 UNK 0
125569802 12556980 13 C BLINATUMOMAB BLINATUMOMAB 1 UNK 0
125569802 12556980 14 C CLOFARABINE CLOFARABINE 1 UNK 0
125569802 12556980 15 C CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125569802 12556980 1 Acute lymphocytic leukaemia recurrent
125569802 12556980 2 Acute lymphocytic leukaemia recurrent
125569802 12556980 3 Acute lymphocytic leukaemia
125569802 12556980 4 Bone marrow conditioning regimen
125569802 12556980 6 Acute lymphocytic leukaemia recurrent
125569802 12556980 8 Bone marrow conditioning regimen
125569802 12556980 9 Prophylaxis against graft versus host disease
125569802 12556980 10 Prophylaxis against graft versus host disease

Outcome of event

Event ID CASEID OUTC COD
125569802 12556980 OT
125569802 12556980 HO
125569802 12556980 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
125569802 12556980 Acute lymphocytic leukaemia
125569802 12556980 Disease progression
125569802 12556980 Disease recurrence
125569802 12556980 Graft versus host disease
125569802 12556980 Neutropenia
125569802 12556980 Pleural effusion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125569802 12556980 1 20141001 0
125569802 12556980 2 20141001 0
125569802 12556980 3 20141117 0
125569802 12556980 4 20141001 0
125569802 12556980 5 201505 0
125569802 12556980 6 20141117 0
125569802 12556980 7 20160408 0
125569802 12556980 8 201505 0
125569802 12556980 9 201505 20151108 0
125569802 12556980 10 201505 20160323 0
125569802 12556980 11 20141117 0
125569802 12556980 12 20141001 0
125569802 12556980 13 20150414 20150512 0
125569802 12556980 14 20160408 0
125569802 12556980 15 20160408 0